Semaglutide Once Weekly In Persons with Type 2 Diabetes: Real-World Analysis of the Colombian Diabetes Registry (COL-REAL 1 Study)

被引：1
|
作者：
Mario Balcazar, Carlos [1 ]
Zambrano, Jose [1 ]
Felipe Garcia, Andres [1 ]
Eugenia Casanova, Maria [1 ]
机构：
[1] Libre Univ, Interinstitut Grp Internal Med GIMI 1, Div Internal Med, Cali, Colombia
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 116卷
关键词：
Type; 2; Diabetes; HbA1c; weight; Semaglutide and Glucagon like peptide-1 receptor agonists;
D O I：
10.1016/j.metabol.2020.154640
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0173
引用
收藏
页码：69 / 70
页数：4
相关论文
共 50 条
  • [1] Semaglutide once weekly in people with type 2 diabetes: Real-world analysis of the CanadianLMCdiabetes registry (SPAREstudy)
    Brown, Ruth E.
    Bech, Peter G.
    Aronson, Ronnie
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2013 - 2020
  • [2] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [3] Efficacy and Safety of Once-Weekly Semaglutide in People with Type 1 Diabetes in Real-World Practice
    Bellido, Virginia
    Herguido, Noelia Gros
    Amuedo, Sandra
    Ariza, Luis Baena
    Alfonso, Soto M.
    [J]. DIABETES, 2023, 72
  • [4] Semaglutide in Patients with Type 2 Diabetes: Real-World Analysis in the Canadian LMC Diabetes Registry: The SPARE Study
    Brown, Ruth E.
    Liu, Aiden R.
    Mahbubani, Reena
    Aronson, Ronnie
    [J]. DIABETES, 2019, 68
  • [5] Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic
    Hansen, Katrine B.
    Svendstrup, Mathilde
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    Vestergaard, Henrik
    [J]. DIABETIC MEDICINE, 2021, 38 (10)
  • [6] Real-world use of once-weekly semaglutide in type 2 diabetes: Results from the SURE UK study
    Holmes, P.
    Catarig, A. M.
    Clark, A.
    Erhan, U.
    Sathyapalan, T.
    [J]. DIABETIC MEDICINE, 2021, 38
  • [7] Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme
    Yale, Jean-Francois
    Major-Pedersen, Atheline
    Catarig, Andrei-Mircea
    Jain, Rashmi
    Menzen, Markus
    Holmes, Patrick
    [J]. DIABETES OBESITY & METABOLISM, 2024,
  • [8] Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
    Garcia de Lucas, Maria Dolores
    Pablo Miramontes-Gonzalez, Jose
    Aviles-Bueno, Beatriz
    Isabel Jimenez-Millan, Ana
    Rivas-Ruiz, Francisco
    Perez-Belmonte, Luis M.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] Safety profile of once-weekly subcutaneous semaglutide in a real-world adult population with type 2 diabetes
    Yale, J. -F.
    Major-Pedersen, A.
    Catarig, A. -M.
    Jain, R. G.
    Menzen, M.
    Holmes, P.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S339 - S340
  • [10] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Wolffenbuttel, Bruce H. R.
    Brugts, Michel P.
    Catarig, Andrei-Mircea
    Clark, Alice
    Kok, Maarten
    Lieverse, Aloysius G.
    van Soest, Jaap
    [J]. ADVANCES IN THERAPY, 2023, 40 (03) : 920 - 933
12345